Melusin, a muscle-specific integrin β1–interacting protein, is required to prevent cardiac failure in response to chronic pressure overload

Cardiac hypertrophy is an adaptive response to a variety of mechanical and hormonal stimuli, and represents an early event in the clinical course leading to heart failure. By gene inactivation, we demonstrate here a crucial role of melusin, a muscle-specific protein that interacts with the integrin β1 cytoplasmic domain, in the hypertrophic response to mechanical overload. Melusin-null mice showed normal cardiac structure and function in physiological conditions, but when subjected to pressure overload—a condition that induces a hypertrophic response in wild-type controls—they developed an abnormal cardiac remodeling that evolved into dilated cardiomyopathy and contractile dysfunction. In contrast, the hypertrophic response was identical in wild-type and melusin-null mice after chronic administration of angiotensin II or phenylephrine at doses that do not increase blood pressure—that is, in the absence of cardiac biomechanical stress. Analysis of intracellular signaling events induced by pressure overload indicated that phosphorylation of glycogen synthase kinase-3β (GSK-3β) was specifically blunted in melusin-null hearts. Thus, melusin prevents cardiac dilation during chronic pressure overload by specifically sensing mechanical stress.

[1]  W. Koch,et al.  Genetic Alterations That Inhibit In Vivo Pressure-Overload Hypertrophy Prevent Cardiac Dysfunction Despite Increased Wall Stress , 2002, Circulation.

[2]  S. Cherry,et al.  Cardiac Myocyte-Specific Excision of the &bgr;1 Integrin Gene Results in Myocardial Fibrosis and Cardiac Failure , 2002, Circulation research.

[3]  C. Ruwhof,et al.  Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways. , 2000, Cardiovascular research.

[4]  A. Clerk,et al.  Cellular mechanisms of cardiac hypertrophy , 1998, Journal of Molecular Medicine.

[5]  Martin A. Schwartz,et al.  Networks and crosstalk: integrin signalling spreads , 2002, Nature Cell Biology.

[6]  L. Silengo,et al.  Differential onset of expression of alpha 7 and beta 1D integrins during mouse heart and skeletal muscle development. , 1998, Cell adhesion and communication.

[7]  IsseiKomuro,et al.  Pressure Overload Induces Cardiac Hypertrophy in Angiotensin II Type 1A Receptor Knockout Mice , 1998 .

[8]  Y. Wang Signal transduction in cardiac hypertrophy--dissecting compensatory versus pathological pathways utilizing a transgenic approach. , 2001, Current opinion in pharmacology.

[9]  E. Olson,et al.  Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[10]  T. Doetschman,et al.  TGF-β1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II , 2002 .

[11]  Robert J. Lefkowitz,et al.  Seven-transmembrane-spanning receptors and heart function , 2002, Nature.

[12]  J. Sadoshima,et al.  Mechanical stretch rapidly activates multiple signal transduction pathways in cardiac myocytes: potential involvement of an autocrine/paracrine mechanism. , 1993, The EMBO journal.

[13]  L. Silengo,et al.  Muscle β1D Integrin Reinforces the Cytoskeleton–Matrix Link: Modulation of Integrin Adhesive Function by Alternative Splicing , 1997, The Journal of cell biology.

[14]  K. Chien,et al.  Signaling pathways for cardiac hypertrophy and failure. , 1999, The New England journal of medicine.

[15]  R. Fässler,et al.  Differentiation and integrity of cardiac muscle cells are impaired in the absence of beta 1 integrin. , 1996, Journal of cell science.

[16]  W. MacLellan,et al.  Advances in the molecular mechanisms of heart failure , 2000, Current opinion in cardiology.

[17]  K. Chien,et al.  Stress Pathways and Heart Failure , 1999, Cell.

[18]  E. Olson,et al.  Converging Pathways and Principles in Heart Development and Disease CV@CSH , 2002, Cell.

[19]  G. Aurigemma,et al.  Heart failure in pressure overload hypertrophy. The relative roles of ventricular remodeling and myocardial dysfunction. , 2002, Journal of the American College of Cardiology.

[20]  J. Ross,et al.  Elevated blood pressure and enhanced myocardial contractility in mice with severe IGF-1 deficiency. , 1996, The Journal of clinical investigation.

[21]  P. Stein,et al.  A PKC-eta/Fyn-dependent pathway leading to keratinocyte growth arrest and differentiation. , 2000, Molecular cell.

[22]  S. Dedhar,et al.  Regulation of Protein Kinase B/Akt-Serine 473 Phosphorylation by Integrin-linked Kinase , 2001, The Journal of Biological Chemistry.

[23]  E. Olson,et al.  Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy , 2001, The EMBO journal.

[24]  G. Dorn,et al.  Gq signaling in cardiac adaptation and maladaptation. , 1999, Trends in cardiovascular medicine.

[25]  G. King,et al.  Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[26]  H. Drexler,et al.  The cardiac Fas (APO-1/CD95) Receptor/Fas ligand system : relation to diastolic wall stress in volume-overload hypertrophy in vivo and activation of the transcription factor AP-1 in cardiac myocytes. , 2000, Circulation.

[27]  J. Sadoshima,et al.  The cellular and molecular response of cardiac myocytes to mechanical stress. , 1997, Annual review of physiology.

[28]  M. Schwartz,et al.  Integrins: emerging paradigms of signal transduction. , 1995, Annual review of cell and developmental biology.

[29]  R Aikawa,et al.  Endothelin-1 Is Involved in Mechanical Stress-induced Cardiomyocyte Hypertrophy (*) , 1996, The Journal of Biological Chemistry.

[30]  J. Woodgett,et al.  Glycogen Synthase Kinase-3β Is a Negative Regulator of Cardiomyocyte Hypertrophy , 2000, The Journal of cell biology.

[31]  R. Lefkowitz,et al.  Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. , 1998, Science.

[32]  G. Stassi,et al.  Increased cardiomyocyte apoptosis and changes in proapoptotic and antiapoptotic genes bax and bcl-2 during left ventricular adaptations to chronic pressure overload in the rat. , 1999, Circulation.

[33]  C. Pham,et al.  Disruption of integrin function in the murine myocardium leads to perinatal lethality, fibrosis, and abnormal cardiac performance. , 2001, The American journal of pathology.

[34]  P. Cohen,et al.  The renaissance of GSK3 , 2001, Nature Reviews Molecular Cell Biology.

[35]  L. Silengo,et al.  Melusin Is a New Muscle-specific Interactor for β1Integrin Cytoplasmic Domain* , 1999, The Journal of Biological Chemistry.

[36]  A. Zeiher,et al.  Fas receptor signaling inhibits glycogen synthase kinase 3 beta and induces cardiac hypertrophy following pressure overload. , 2002, The Journal of clinical investigation.

[37]  J. Ross,et al.  Loss of a gp130 Cardiac Muscle Cell Survival Pathway Is a Critical Event in the Onset of Heart Failure during Biomechanical Stress , 1999, Cell.

[38]  W. MacLellan,et al.  Genetic dissection of cardiac growth control pathways. , 2000, Annual review of physiology.

[39]  J. Heino,et al.  Upregulation of Collagen Gene Transcription by a Mechanism Involving the a 2 Cytoplasmic Tail , 1999 .

[40]  K. Chien,et al.  Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Gαq/Gα11 in cardiomyocytes , 2001, Nature Medicine.

[41]  L. Fratta,et al.  Cardiovascular Influences of &agr;1b-Adrenergic Receptor Defect in Mice , 2002, Circulation.

[42]  S. Vatner,et al.  Glycogen Synthase Kinase 3β Regulates GATA4 in Cardiac Myocytes* , 2001, The Journal of Biological Chemistry.